Status:
COMPLETED
Changes in Adrenal Hormones During Adrenal Radiofrequency Ablation
Lead Sponsor:
Mie University
Conditions:
Adrenal Tumors
Eligibility:
All Genders
20+ years
Phase:
PHASE2
PHASE3
Brief Summary
The purpose of this study is to evaluate changes in adrenal hormones during adrenal radiofrequency (RF) ablation.
Detailed Description
Adrenal radiofrequency (RF) ablation has been increasingly used for the treatment of unresectable adrenal tumors. But one of the major complication is a increase in blood pressure. Hormonal release du...
Eligibility Criteria
Inclusion
- Unresectable adrenal tumor which will be treated by radiofrequency (RF)ablation
- Blood pressure is 140mmHg or less before RF ablation
- Age of 20-years or more
- Performance status of 0 or 1
- Agreement from the patient
Exclusion
- Platelet count of 50,000/mm\^3 or International normalized ratio (INR)\>1.5
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2010
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT00997594
Start Date
October 1 2009
End Date
October 1 2010
Last Update
April 28 2015
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Mie University Hospital
Tsu, Mie-ken, Japan, 514-8507
2
Mie University
Tsu, Mie-ken, Japan, 514-8507